bispecific antibody
-
I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares
For more DrugTimes bio-news, please follow DrugTimes. Many thanks!
-
I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health
For more bio-news, please follow DrugTimes. Many thanks!
-
The biggest biotech financing of the year has been born! Who will be the next “buyer”?
What will be the fate of this new player in autoimmune diseases in the future?
-
American listed companies are looking for innovative ADCs and bispecific antibodies. Are you interested in this opportunity? | DrugTimes BD Project
Please contact the DrugTimes BD team as soon as possible!
-
Roche’s bispecific antibody therapy sets a new record as the “king of drugs” in ophthalmology
DrugTimes Team will follow up on this subject. Please stay tuned
-
CLDN6 X 4-1BB bispecific antibody 【Product for Licensing】
If interested, please contact DrugTimes BD Team at BD@drugtimes.cn. Many thanks!
